XML 141 R125.htm IDEA: XBRL DOCUMENT v3.6.0.2
Schedule II - Condensed Statements Of Cash Flows (Detail) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Investment income received $ 318 $ 353 $ 419
Operating expenses paid (136) (130) (238)
Interest paid, net of interest converted to principal (139) (169) (179)
Income taxes (paid) received (5) (9) (17)
Net cash provided (used) by operating activities (142) (55) (333)
Cash flows from investing activities:      
Purchases of available-for-sale investments (2,661) (2,146) (1,494)
Sales of available-for-sale investments 2,412 1,145 757
Paydowns and maturities of available-for-sale investments 680 800 484
Purchases of investments at fair value (199) (390) (631)
Sales, paydowns and maturities of investments at fair value 260 551 789
Sales, paydowns and maturities (purchases) of short-term investments, net (125) 525 515
(Payments) proceeds for derivative settlements (44) 13 (26)
Collateral (to) from swap counterparty 49 (31) 144
Other investing (8) 47 1
Net cash provided (used) by investing activities 2,424 817 812
Cash flows from financing activities:      
Proceeds from investment agreements 19 24 30
Principal paydowns of investment agreements (85) (116) (192)
Principal paydowns of long-term debt 0 (11) 0
Purchases of treasury stock (108) (303) (32)
Net cash provided (used) by financing activities (2,542) (1,014) (892)
Effect of exchange rate changes on cash and cash equivalents (2) (8) (8)
Net increase (decrease) in cash and cash equivalents (262) (260) (421)
Cash and cash equivalents - beginning of year 522 782 1,258
Reclassification to assets held for sale (73) 0 (55)
Cash and cash equivalents - end of year 187 522 782
Reconciliation of net income (loss) to net cash provided (used) by operating activities: [Abstract]      
Net income (loss) (338) 180 569
Change in: [Abstract]      
Dividends from subsidiaries 118 114  
Net investment losses related to other-than-temporary impairments 5 13 15
Net (gains) losses on financial instruments at fair value and foreign exchange (84) (105) (128)
Other net realized (gains) losses 282 (17) (25)
Deferred income tax provision (benefit) (5) 107 50
Other operating 36 38 114
Total adjustments to net income (loss) 196 (235) (902)
Net cash provided (used) by operating activities (142) (55) (333)
Parent Company [Member]      
Cash flows from operating activities:      
Fees and reimbursements received 4 0 1
Investment income received 144 142 256
Operating expenses paid (19) (25) (35)
Interest paid, net of interest converted to principal (84) (88) (93)
Income taxes (paid) received 73 108 59
Net cash provided (used) by operating activities 118 137 188
Cash flows from investing activities:      
Purchases of available-for-sale investments (129) (606) (125)
Sales of available-for-sale investments 165 325 268
Paydowns and maturities of available-for-sale investments 90 186 98
Purchases of investments at fair value (57) (144) (266)
Sales, paydowns and maturities of investments at fair value 58 171 280
Sales, paydowns and maturities (purchases) of short-term investments, net 1 232 (242)
(Payments) proceeds for derivative settlements (37) 43 (26)
Collateral (to) from swap counterparty 52 (31) 144
Contributions to subsidiaries, net (10) 16 (20)
Advances to subsidiaries, net 0 0 (12)
Other investing 0 24 0
Net cash provided (used) by investing activities 133 216 99
Cash flows from financing activities:      
Proceeds from investment agreements 16 21 23
Principal paydowns of investment agreements (80) (111) (181)
Principal paydowns of long-term debt 0 (11) 0
Payments for affiliate loans (111) (103) (153)
Purchases of treasury stock (106) (233) (32)
Restricted stock awards settlements 8 19 16
Net cash provided (used) by financing activities (273) (418) (327)
Net increase (decrease) in cash and cash equivalents (22) (65) (40)
Cash and cash equivalents - beginning of year 35 100 140
Cash and cash equivalents - end of year 13 35 100
Reconciliation of net income (loss) to net cash provided (used) by operating activities: [Abstract]      
Net income (loss) (338) 180 569
Change in: [Abstract]      
Intercompany accounts receivable (10) (21) (24)
Current income taxes 78 109 70
Equity in earnings of subsidiaries 262 (189) (463)
Dividends from subsidiaries 118 116 225
Net investment losses related to other-than-temporary impairments 1 4 0
Net (gains) losses on financial instruments at fair value and foreign exchange 13 (59) (24)
Other net realized (gains) losses 5 (21) (1)
Deferred income tax provision (benefit) (20) 0 (176)
(Gains) losses on extinguishment of debt (5) 0 (1)
Other operating 14 18 13
Total adjustments to net income (loss) 456 (43) (381)
Net cash provided (used) by operating activities $ 118 $ 137 $ 188